HOYLU AB: HOYLU RECEIVES ORDER FROM PHARMA COMPANY
Stockholm, Sweden, April 17, 2019 – Hoylu, a leading enterprise collaboration company announced today that it has received an order from a new customer in the pharma sector, Foundation Medicine (www.FoundationMedicine.com). The deal value is SEK 400,000 in software and product revenue.
Hoylu’s software and solutions offer new and exciting ways to learn, communicate and collaborate smarter, faster and more efficiently. Create connected workspaces that include engineering plans, design reviews, and analyze large data sets on large scale HoyluWalls or any device you choose. Hoylu Suite is designed to make digital work simple, seamless and hassle free.
For more information, please contact:
Stein Revelsby, CEO at Hoylu +1 213 440 2499 Email: firstname.lastname@example.org
Karl Wiersholm, CFO at Hoylu +1 425 829 2316 Email: email@example.com
Hoylu delivers innovative enterprise solutions to allow global teams to collaboratively plan, create and share information that enrichen the user experience in the virtual office. The Hoylu Suite delivers a comprehensive set of personalized connected workspaces to enable teams across locations, on any device, to work smarter and with more fun across major industries including Engineering, Education, Pharmaceutical, Construction, Manufacturing, Graphic Design and many more. For more information: www.hoylu.com or visit www.introduce.se/foretag/hoylu
Ticker symbol: Hoylu
Marketplace: Nasdaq First North Stockholm
Certified Adviser: Mangold Fondkommission AB +46 (0) 8 50 301 550
This information is information that Hoylu AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at (8:45) CEST on April 17, 2019